ALERT: Severe weather is heading to our area, and we want to be sure that you and your family are prepared. We will continue to share updates with important resources as they become available. Learn more
Se acerca un clima severo a nuestra área y queremos asegurarnos de que tú y tu familia estén preparados. Continuaremos compartiendo actualizaciones con recursos importantes a medida que estén disponibles. Más información
Cold and flu seasonTemporada de influenza y resfriados
ALERT:Stay healthy this cold and flu season!Learn more
ALERTA: ¡Mantente sano durante esta temporada de influenza y resfriados!Más información
Reimbursement Rate Updates for COVID-19 Pfizer Vaccine Administration Procedure Codes 0071A and 0072A
Date: November 22, 2021
Attention: All Providers, including pharmacists
Effective Date: Dates of service on or after October 29, 2021Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event. TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event.Call to action: For dates of service on or after October 29, 2021, the reimbursement rates for COVID-19 Pfizer vaccine administration procedure codes 0071A (first dose) and 0072A (second dose) will be implemented for Texas Medicaid and the Children with Special Health Care Needs (CSHCN) Services Program. How this impacts providers: This applies to patients five years old and older. Dose information is as follows:
First dose—0071A- Pfizer Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation
Second dose— 0072A-Pfizer Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation